These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 29186281)

  • 1. EU/US/CTAD Task Force: Lessons Learned from Recent and Current Alzheimer's Prevention Trials.
    Aisen P; Touchon J; Amariglio R; Andrieu S; Bateman R; Breitner J; Donohue M; Dunn B; Doody R; Fox N; Gauthier S; Grundman M; Hendrix S; Ho C; Isaac M; Raman R; Rosenberg P; Schindler R; Schneider L; Sperling R; Tariot P; Welsh-Bohmer K; Weiner M; Vellas B
    J Prev Alzheimers Dis; 2017; 4(2):116-124. PubMed ID: 29186281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force.
    Vellas B; Carrillo MC; Sampaio C; Brashear HR; Siemers E; Hampel H; Schneider LS; Weiner M; Doody R; Khachaturian Z; Cedarbaum J; Grundman M; Broich K; Giacobini E; Dubois B; Sperling R; Wilcock GK; Fox N; Scheltens P; Touchon J; Hendrix S; Andrieu S; Aisen P;
    Alzheimers Dement; 2013 Jul; 9(4):438-44. PubMed ID: 23809364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platform Trials to Expedite Drug Development in Alzheimer's Disease: A Report from the EU/US CTAD Task Force.
    Aisen PS; Bateman RJ; Carrillo M; Doody R; Johnson K; Sims JR; Sperling R; Vellas B
    J Prev Alzheimers Dis; 2021; 8(3):306-312. PubMed ID: 34101788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using Digital Tools to Advance Alzheimer's Drug Trials During a Pandemic: The EU/US CTAD Task Force.
    Kaye J; Aisen P; Amariglio R; Au R; Ballard C; Carrillo M; Fillit H; Iwatsubo T; Jimenez-Maggiora G; Lovestone S; Natanegara F; Papp K; Soto ME; Weiner M; Vellas B
    J Prev Alzheimers Dis; 2021; 8(4):513-519. PubMed ID: 34585227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease therapeutic trials: EU/US Task Force report on recruitment, retention, and methodology.
    Vellas B; Hampel H; Rougé-Bugat ME; Grundman M; Andrieu S; Abu-Shakra S; Bateman R; Berman R; Black R; Carrillo M; Donohue M; Mintun M; Morris J; Petersen R; Thomas RG; Suhy J; Schneider L; Seely L; Tariot P; Touchon J; Weiner M; Sampaio C; Aisen P;
    J Nutr Health Aging; 2012 Apr; 16(4):339-45. PubMed ID: 22499454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention trials in Alzheimer's disease: an EU-US task force report.
    Vellas B; Aisen PS; Sampaio C; Carrillo M; Scheltens P; Scherrer B; Frisoni GB; Weiner M; Schneider L; Gauthier S; Gispen-de Wied CC; Hendrix S; Feldman H; Cedarbaum J; Petersen R; Siemers E; Andrieu S; Prvulovic D; Touchon J; Hampel H
    Prog Neurobiol; 2011 Dec; 95(4):594-600. PubMed ID: 21925234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advancing Alzheimer's Disease Treatment: Lessons from CTAD 2018.
    Vellas B; Bain LJ; Touchon J; Aisen PS
    J Prev Alzheimers Dis; 2019; 6(3):198-203. PubMed ID: 31062835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endpoints for Pre-Dementia AD Trials: A Report from the EU/US/CTAD Task Force.
    Vellas B; Bateman R; Blennow K; Frisoni G; Johnson K; Katz R; Langbaum J; Marson D; Sperling R; Wessels A; Salloway S; Doody R; Aisen P;
    J Prev Alzheimers Dis; 2015 Jun; 2(2):128-135. PubMed ID: 26247004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination Therapy for Alzheimer's Disease: Perspectives of the EU/US CTAD Task Force.
    Gauthier S; Alam J; Fillit H; Iwatsubo T; Liu-Seifert H; Sabbagh M; Salloway S; Sampaio C; Sims JR; Sperling B; Sperling R; Welsh-Bohmer KA; Touchon J; Vellas B; Aisen P
    J Prev Alzheimers Dis; 2019; 6(3):164-168. PubMed ID: 31062826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying Better Outcome Measures to Improve Treatment of Agitation in Dementia: A Report from the EU/US/CTAD Task Force.
    Sano M; Soto M; Carrillo M; Cummings J; Hendrix S; Mintzer J; Porsteinsson A; Rosenberg P; Schneider L; Touchon J; Aisen P; Vellas B; Lyketsos C
    J Prev Alzheimers Dis; 2018; 5(2):98-102. PubMed ID: 29616702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Report of the task force on designing clinical trials in early (predementia) AD.
    Aisen PS; Andrieu S; Sampaio C; Carrillo M; Khachaturian ZS; Dubois B; Feldman HH; Petersen RC; Siemers E; Doody RS; Hendrix SB; Grundman M; Schneider LS; Schindler RJ; Salmon E; Potter WZ; Thomas RG; Salmon D; Donohue M; Bednar MM; Touchon J; Vellas B
    Neurology; 2011 Jan; 76(3):280-6. PubMed ID: 21178097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Meaningfulness in Alzheimer's Disease Clinical Trials. A Report from the EU-US CTAD Task Force.
    Angioni D; Cummings J; Lansdall CJ; Middleton L; Sampaio C; Gauthier S; Cohen S; Petersen RC; Rentz DM; Wessels AM; Hendrix SB; Jessen F; Carrillo MC; Doody RS; Irizarry M; Andrews JS; Vellas B; Aisen P
    J Prev Alzheimers Dis; 2024; 11(5):1219-1227. PubMed ID: 39350367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarker and Clinical Trial Design Support for Disease-Modifying Therapies: Report of a Survey of the EU/US: Alzheimer's Disease Task Force.
    Cummings J; Fox N; Vellas B; Aisen P; Shan G
    J Prev Alzheimers Dis; 2018; 5(2):103-109. PubMed ID: 29616703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Biomarkers of AD Emerging as Essential Tools for Drug Development: An EU/US CTAD Task Force Report.
    Bateman RJ; Blennow K; Doody R; Hendrix S; Lovestone S; Salloway S; Schindler R; Weiner M; Zetterberg H; Aisen P; Vellas B
    J Prev Alzheimers Dis; 2019; 6(3):169-173. PubMed ID: 31062827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Tau Trials for Alzheimer's Disease: A Report from the EU/US/CTAD Task Force.
    Cummings J; Blennow K; Johnson K; Keeley M; Bateman RJ; Molinuevo JL; Touchon J; Aisen P; Vellas B
    J Prev Alzheimers Dis; 2019; 6(3):157-163. PubMed ID: 31062825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What Have We Learned from Expedition III and EPOCH Trials? Perspective of the CTAD Task Force.
    Aisen PS; Siemers E; Michelson D; Salloway S; Sampaio C; Carrillo MC; Sperling R; Doody R; Scheltens P; Bateman R; Weiner M; Vellas B
    J Prev Alzheimers Dis; 2018; 5(3):171-174. PubMed ID: 29972209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention Trials in Alzheimer's Disease: Current Status and Future Perspectives.
    Wang J; Tan L; Yu JT
    J Alzheimers Dis; 2016; 50(4):927-45. PubMed ID: 26836177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood Biomarkers from Research Use to Clinical Practice: What Must Be Done? A Report from the EU/US CTAD Task Force.
    Angioni D; Delrieu J; Hansson O; Fillit H; Aisen P; Cummings J; Sims JR; Braunstein JB; Sabbagh M; Bittner T; Pontecorvo M; Bozeat S; Dage JL; Largent E; Mattke S; Correa O; Gutierrez Robledo LM; Baldivieso V; Willis DR; Atri A; Bateman RJ; Ousset PJ; Vellas B; Weiner M
    J Prev Alzheimers Dis; 2022; 9(4):569-579. PubMed ID: 36281661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing pharmaceutical trials for sarcopenia in frail older adults: EU/US Task Force recommendations.
    Vellas B; Pahor M; Manini T; Rooks D; Guralnik JM; Morley J; Studenski S; Evans W; Asbrand C; Fariello R; Pereira S; Rolland Y; Abellan van Kan G; Cesari M; Chumlea WC; Fielding R
    J Nutr Health Aging; 2013 Jul; 17(7):612-8. PubMed ID: 23933872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Registries and Cohorts to Accelerate Early Phase Alzheimer's Trials. A Report from the E.U./U.S. Clinical Trials in Alzheimer's Disease Task Force.
    Aisen P; Touchon J; Andrieu S; Boada M; Doody R; Nosheny RL; Langbaum JB; Schneider L; Hendrix S; Wilcock G; Molinuevo JL; Ritchie C; Ousset PJ; Cummings J; Sperling R; DeKosky ST; Lovestone S; Hampel H; Petersen R; Legrand V; Egan M; Randolph C; Salloway S; Weiner M; Vellas B
    J Prev Alzheimers Dis; 2016; 3(2):68-74. PubMed ID: 29210442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.